(Q80773011)
Statements
Economic evaluation of docetaxel/gemcitabine versus docetaxel as frontline treatment of patients with advanced/metastatic non-small cell lung cancer in Greece (English)
N Maniadakis
V Fragoulakis
A Pallis
P Prezerakos